Who Paid My Doc
Vyleesi
Drug Hypoactive Sexual Desire Disorder Hsdd
NDC 64011-701-04
General payments
$236,870
Research payments
$628,833
Through program year 2020, $236,870 in general payments and $628,833 in research payments were reported against Vyleesi (Hypoactive Sexual Desire Disorder Hsdd).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $41,487 | 2,148 |
| 2019 | General | $195,383 | 3,568 |
| 2019 | Research | $628,833 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
5,716 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.